Kodai Senga's ulnar nerve irritation is the latest setback for the Mets' right-hander, who has been plagued by injuries since his major league debut. Senga, the 2023 National League Rookie of the Year runner-up, was expected to be a star, but injuries have negatively defined his time in the majors. This latest issue raises questions about his long-term production and the Mets' rotation plans.
Senga's journey has been a rollercoaster. He started the 2025 season strong, but an injury in June derailed his campaign. He was placed on the IL with lumbar spine inflammation on April 28, and his rehab starts have been less than impressive. With a 6.00 ERA across 12 innings, his velocity and command have been a concern. The Mets' decision to give him another outing despite subpar results is a testament to their cautious approach.
The ulnar nerve irritation is a significant issue, as it can affect a pitcher's ability to throw with power and accuracy. It's a reminder that even the most talented athletes are susceptible to injuries, and the Mets' management must be cautious in their handling of Senga's recovery. The club's reliance on reliable starters like Christian Scott and Nolan McLean is a strategic move, but the need for a fifth starter on June 13 is a pressing concern.
The Mets' internal options for the fifth starter role include prospects Zack Thorton and Jack Wenninger. The organization must carefully consider these options, as the success of their rotation is crucial for their playoff hopes. Senga's injury history and the team's cautious approach suggest that the Mets will need to be patient and strategic in their rebuilding process.
In my opinion, the Mets' management has shown a thoughtful approach to Senga's recovery and the team's overall strategy. However, the ulnar nerve irritation is a serious concern that could impact Senga's long-term prospects. The organization must continue to monitor his progress and make informed decisions to ensure the team's success.
